glp 1 drugs and multiple sclerosis Glucagon-like peptide-1 medicines in neurological psychiatric disorders: Cell Reports Medicine Episode 444: A GLP-1 Drug

showed that despite the presence of visual symptoms in 14% of patients at discharge, the frequency of the occurrence of persistent visual sequela in the 38 month period of follow-up increased to 40%, and blindness affected 8% of patients (Zakharov et al

Zinc contributes to normal cognitive function

445 Immunotherapeutic treatments have shown significant efficacy in TNBCs due to tumor immune infiltration, neoantigens caused by mutational burden and higher genomic instability, and high levels of immune markers such as PD-L1 and programmed cell death 1 (PD-1)

Side Effects You can get mild to moderate Side Effects when using the drug

As a result, cancer researchers emphasize identifying the biological processes that drive cancerous cells to migrate and potential strategies to inhibit metastasis (Zuazo-Gaztelu and Casanovas, 2018)